Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOHN C LIM

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1508899493
CMS profile
67948
Location
TORRANCE, CA

General Payments · PY2018–2024

$3,183.05

  • Reported across 166 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$340.02

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $340.02 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $847.35 45
PY2019 $523.07 30
PY2020 $226.05 11
PY2021 $597.59 31
PY2022 $406.70 20
PY2023 $242.27 13
PY2024 $340.02 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ASCEND THERAPEUTICS US, LLC $18.73 03/22/2024 Food and Beverage Undisputed 01/23/2026 1146422297 CMS
Exact Sciences Corporation $20.26 08/01/2024 Food and Beverage Undisputed 01/23/2026 1114758036 CMS
Exeltis, USA Inc. $18.48 10/24/2024 Food and Beverage Undisputed 01/23/2026 1149997950 CMS
Heron Therapeutics, Inc. $25.62 08/30/2024 Food and Beverage Undisputed 01/23/2026 1147247465 CMS
Heron Therapeutics, Inc. $23.35 12/21/2024 Food and Beverage Undisputed 01/23/2026 1147247467 CMS
Lilly USA, LLC $28.60 01/29/2024 Food and Beverage Undisputed 01/23/2026 1135070189 CMS
Lilly USA, LLC $31.66 04/03/2024 Food and Beverage Undisputed 01/23/2026 1135055984 CMS
Lilly USA, LLC $33.30 08/21/2024 Food and Beverage Undisputed 01/23/2026 1135068177 CMS
MAYNE PHARMA COMMERCIAL LLC $7.34 08/23/2024 Food and Beverage Undisputed 01/23/2026 1154662727 CMS
MAYNE PHARMA COMMERCIAL LLC $9.09 12/13/2024 Food and Beverage Undisputed 01/23/2026 1154662729 CMS
MILLICENT US INC $18.82 07/30/2024 Food and Beverage Undisputed 01/23/2026 1150909181 CMS
MILLICENT US INC $17.06 10/03/2024 Food and Beverage Undisputed 01/23/2026 1150909183 CMS
MILLICENT US INC $20.45 10/22/2024 Food and Beverage Undisputed 01/23/2026 1150909185 CMS
Novo Nordisk Inc $22.94 05/16/2024 Food and Beverage Undisputed 01/23/2026 1097722595 CMS
Radius Health, Inc. $23.35 06/10/2024 Food and Beverage Undisputed 01/23/2026 1089961918 CMS
Sumitomo Pharma America, Inc. $20.97 05/29/2024 Food and Beverage Undisputed 01/23/2026 1148882084 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.